ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $731,391 | -73.1% | 35,695 | -73.9% | 0.00% | -100.0% |
| Q2 2023 | $2,719,031 | +546.5% | 136,841 | +457.4% | 0.00% | – |
| Q1 2023 | $420,576 | +30.6% | 24,552 | +49.2% | 0.00% | – |
| Q4 2022 | $321,985 | +77.9% | 16,453 | +45.0% | 0.00% | – |
| Q3 2022 | $181,000 | +1.1% | 11,346 | -12.7% | 0.00% | – |
| Q2 2022 | $179,000 | -25.1% | 12,996 | +19.0% | 0.00% | – |
| Q4 2021 | $239,000 | -78.5% | 10,925 | -70.6% | 0.00% | – |
| Q3 2021 | $1,111,000 | -42.0% | 37,165 | -14.1% | 0.00% | -100.0% |
| Q2 2021 | $1,917,000 | +61.1% | 43,288 | +61.4% | 0.00% | – |
| Q1 2021 | $1,190,000 | -36.1% | 26,817 | -21.0% | 0.00% | -100.0% |
| Q4 2020 | $1,861,000 | +309.9% | 33,935 | +70.9% | 0.00% | – |
| Q3 2020 | $454,000 | – | 19,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |